These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 11027455)

  • 1. Safety and immune responses to attenuated Salmonella enterica serovar typhi oral live vector vaccines expressing tetanus toxin fragment C.
    Tacket CO; Galen J; Sztein MB; Losonsky G; Wyant TL; Nataro J; Wasserman SS; Edelman R; Chatfield S; Dougan G; Levine MM
    Clin Immunol; 2000 Nov; 97(2):146-53. PubMed ID: 11027455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel use of anaerobically induced promoter, dmsA, for controlled expression of fragment C of tetanus toxin in live attenuated Salmonella enterica serovar Typhi strain CVD 908-htrA.
    Orr N; Galen JE; Levine MM
    Vaccine; 2001 Feb; 19(13-14):1694-700. PubMed ID: 11166893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant Salmonella enterica serovar Typhi in a prime-boost strategy.
    Vindurampulle CJ; Cuberos LF; Barry EM; Pasetti MF; Levine MM
    Vaccine; 2004 Sep; 22(27-28):3744-50. PubMed ID: 15315855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers.
    Metzger WG; Mansouri E; Kronawitter M; Diescher S; Soerensen M; Hurwitz R; Bumann D; Aebischer T; Von Specht BU; Meyer TF
    Vaccine; 2004 Jun; 22(17-18):2273-7. PubMed ID: 15149786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and immunogenicity of attenuated Salmonella enterica serovar Typhimurium delivering an HIV-1 Gag antigen via the Salmonella Type III secretion system.
    Kotton CN; Lankowski AJ; Scott N; Sisul D; Chen LM; Raschke K; Borders G; Boaz M; Spentzou A; Galán JE; Hohmann EL
    Vaccine; 2006 Sep; 24(37-39):6216-24. PubMed ID: 16824652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction, genotypic and phenotypic characterization, and immunogenicity of attenuated DeltaguaBA Salmonella enterica serovar Typhi strain CVD 915.
    Wang JY; Pasetti MF; Noriega FR; Anderson RJ; Wasserman SS; Galen JE; Sztein MB; Levine MM
    Infect Immun; 2001 Aug; 69(8):4734-41. PubMed ID: 11447145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuated deltaguaBA Salmonella typhi vaccine strain CVD 915 as a live vector utilizing prokaryotic or eukaryotic expression systems to deliver foreign antigens and elicit immune responses.
    Pasetti MF; Anderson RJ; Noriega FR; Levine MM; Sztein MB
    Clin Immunol; 1999 Jul; 92(1):76-89. PubMed ID: 10413655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosally delivered Salmonella live vector vaccines elicit potent immune responses against a foreign antigen in neonatal mice born to naive and immune mothers.
    Capozzo AV; Cuberos L; Levine MM; Pasetti MF
    Infect Immun; 2004 Aug; 72(8):4637-46. PubMed ID: 15271924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of plasmid stability on oral DNA delivery by Salmonella enterica serovar Typhimurium.
    Gahan ME; Webster DE; Wesselingh SL; Strugnell RA
    Vaccine; 2007 Feb; 25(8):1476-83. PubMed ID: 17126961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic detoxification of an aroA Salmonella enterica serovar Typhimurium vaccine strain does not compromise protection against virulent Salmonella and enhances the immune responses towards a protective malarial antigen.
    McKelvie ND; Khan SA; Karavolos MH; Bulmer DM; Lee JJ; DeMarco R; Maskell DJ; Zavala F; Hormaeche CE; Khan CM
    FEMS Immunol Med Microbiol; 2008 Mar; 52(2):237-46. PubMed ID: 18177343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacteremia associated with live attenuated chi8110 Salmonella enterica serovar Typhi ISP1820 in healthy adult volunteers.
    Frey SE; Bollen W; Sizemore D; Campbell M; Curtiss R
    Clin Immunol; 2001 Oct; 101(1):32-7. PubMed ID: 11580224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo characterization of the murine intranasal model for assessing the immunogenicity of attenuated Salmonella enterica serovar Typhi strains as live mucosal vaccines and as live vectors.
    Pickett TE; Pasetti MF; Galen JE; Sztein MB; Levine MM
    Infect Immun; 2000 Jan; 68(1):205-13. PubMed ID: 10603389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuated Salmonella as live oral vaccines against typhoid fever and as live vectors.
    Levine MM; Galen J; Barry E; Noriega F; Chatfield S; Sztein M; Dougan G; Tacket C
    J Biotechnol; 1996 Jan; 44(1-3):193-6. PubMed ID: 8717403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of phoP and rpoS mutants of Salmonella enterica serovar Typhi as attenuated typhoid vaccine candidates: virulence and protective immune responses in intranasally immunized mice.
    Lee HY; Cho SA; Lee IS; Park JH; Seok SH; Baek MW; Kim DJ; Lee SH; Hur SJ; Ban SJ; Lee YK; Han YK; Cho YK; Park JH
    FEMS Immunol Med Microbiol; 2007 Nov; 51(2):310-8. PubMed ID: 17725620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Salmonella enterica serovar Typhi (Ty2 aroC-ssaV-) M01ZH09, with a defined mutation in the Salmonella pathogenicity island 2, as a live, oral typhoid vaccine in human volunteers.
    Kirkpatrick BD; McKenzie R; O'Neill JP; Larsson CJ; Bourgeois AL; Shimko J; Bentley M; Makin J; Chatfield S; Hindle Z; Fidler C; Robinson BE; Ventrone CH; Bansal N; Carpenter CM; Kutzko D; Hamlet S; LaPointe C; Taylor DN
    Vaccine; 2006 Jan; 24(2):116-23. PubMed ID: 16140433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans.
    Tacket CO; Sztein MB; Losonsky GA; Wasserman SS; Nataro JP; Edelman R; Pickard D; Dougan G; Chatfield SN; Levine MM
    Infect Immun; 1997 Feb; 65(2):452-6. PubMed ID: 9009296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CVD 908, CVD 908-htrA, and CVD 909 live oral typhoid vaccines: a logical progression.
    Tacket CO; Levine MM
    Clin Infect Dis; 2007 Jul; 45 Suppl 1():S20-3. PubMed ID: 17582563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens.
    Galen JE; Gomez-Duarte OG; Losonsky GA; Halpern JL; Lauderbaugh CS; Kaintuck S; Reymann MK; Levine MM
    Vaccine; 1997; 15(6-7):700-8. PubMed ID: 9178472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The novel oral typhoid vaccine M01ZH09 is well tolerated and highly immunogenic in 2 vaccine presentations.
    Kirkpatrick BD; Tenney KM; Larsson CJ; O'Neill JP; Ventrone C; Bentley M; Upton A; Hindle Z; Fidler C; Kutzko D; Holdridge R; Lapointe C; Hamlet S; Chatfield SN
    J Infect Dis; 2005 Aug; 192(3):360-6. PubMed ID: 15995948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaptation of the endogenous Salmonella enterica serovar Typhi clyA-encoded hemolysin for antigen export enhances the immunogenicity of anthrax protective antigen domain 4 expressed by the attenuated live-vector vaccine strain CVD 908-htrA.
    Galen JE; Zhao L; Chinchilla M; Wang JY; Pasetti MF; Green J; Levine MM
    Infect Immun; 2004 Dec; 72(12):7096-106. PubMed ID: 15557633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.